| Ovotransferrin treatment for the reproductive tract J Talukder, A Ray, DJ DuBourdieu, A Srivastava, R Lall US Patent App. 17/146,859, 2021 | | 2021 |
| Ovotransferrin treatment for the reproductive tract RL Jamil Talukder, Abhijit Ray, Daniel J. DuBourdieu, Ajay Srivastava US Patent 10,905,748, 2021 | 2 | 2021 |
| Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2 B Khong, BO Lawson, J Ma, C McGovern, JK Van Atta, A Ray, HT Khong BMC cancer 18, 1-5, 2018 | 3 | 2018 |
| Treatment of Infectious Endometritis with a Novel Protein, VPI‐O22, in Cows J Talukder, A Srivastava, A Ray, R Lall The FASEB Journal 32, 882.12-882.12, 2018 | 2 | 2018 |
| Neutrophil-to-lymphocyte Ratio (NLR) as a predictor for recurrence in patients with stage III melanoma J Ma, J Kuzman, A Ray, BO Lawson, B Khong, S Xuan, AW Hahn, ... Scientific reports 8 (1), 4044, 2018 | 66 | 2018 |
| A phase I study of neoadjuvant chemotherapy with nab-paclitaxel, doxorubicin, and cyclophosphamide in patients with stage II to III breast cancer TL Werner, A Ray, JG Lamb, M VanBrocklin, K Hueftle, AL Cohen, ... Clinical breast cancer 17 (7), 503-509, 2017 | 9 | 2017 |
| Methods for delivering an anti-cancer agent to a tumor H Ghandehari, A Gormley, A Ray, N Larson US Patent App. 15/634,281, 2017 | | 2017 |
| Neutrophil-To-Lymphocyte Ratio (NLR) As A Predictor For Recurrencein Patients With Stage Iii Melanoma J Ma, J Kuzman, A Ray, B Khong, BO Lawson, S Xuan, HT Khong Value in Health 20 (9), A417-A418, 2017 | | 2017 |
| A phase I trial of azacitidine and nanoparticle albumin bound paclitaxel in patients with advanced or metastatic solid tumors AL Cohen, A Ray, M Van Brocklin, DM Burnett, RC Bowen, DL Dyess, ... Oncotarget 8 (32), 52413, 2017 | 24 | 2017 |
| A case report of Pneumocystis jiroveci pneumonia in a patient with metastatic breast cancer A Ray, B Khong, HT Khong Anticancer Research 36 (12), 6673-6676, 2016 | 6 | 2016 |
| A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma A Ray, MA Williams, SM Meek, RC Bowen, KF Grossmann, ... Oncotarget 7 (39), 64390, 2016 | 77 | 2016 |
| HPMA—docetaxel conjugates and uses therefore YB Lee, DJ Kim, CH Ahn, A Nan, H Ghandehari, A Ray US Patent 9,434,610, 2016 | 2 | 2016 |
| Radiation enhanced macromolecular delivery of therapeutic agents for chemotherapy H Ghandehari, A Ray US Patent App. 15/049,198, 2016 | | 2016 |
| Methods for delivering an anti-cancer agent to a tumor H Ghandehari, A Gormley, A Ray, N Larson US Patent App. 14/996,419, 2016 | 2 | 2016 |
| Effects of heating temperature and duration by gold nanorod mediated plasmonic photothermal therapy on copolymer accumulation in tumor tissue N Frazier, R Robinson, A Ray, H Ghandehari Molecular Pharmaceutics 12 (5), 1605-1614, 2015 | 25 | 2015 |
| Methods for delivering an anti-cancer agent to a tumor H Ghandehari, A Gormley, A Ray, N Larson US Patent App. 14/461,888, 2014 | 1 | 2014 |
| In Vitro Synergistic Action of Geldanamycin‐and Docetaxel‐Containing HPMA Copolymer–RGDfK Conjugates Against Ovarian Cancer N Larson, S Roberts, A Ray, B Buckway, DL Cheney, H Ghandehari Macromolecular bioscience 14 (12), 1735-1747, 2014 | 10 | 2014 |
| Gold nanorod-mediated hyperthermia enhances the efficacy of HPMA copolymer-90Y conjugates in treatment of prostate tumors B Buckway, N Frazier, AJ Gormley, A Ray, H Ghandehari Nuclear medicine and biology 41 (3), 282-289, 2014 | 62 | 2014 |
| In Vitro Evaluation of HPMA‐C opolymers Targeted to HER 2 Expressing Pancreatic Tumor Cells for Image Guided Drug Delivery B Buckway, Y Wang, A Ray, H Ghandehari Macromolecular bioscience 14 (1), 92-99, 2014 | 5 | 2014 |
| Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors B Buckway, Y Wang, A Ray, H Ghandehari International journal of pharmaceutics 456 (1), 202-211, 2013 | 35 | 2013 |
HAMIDREZA GHANDEHARIProfessor在 pharm.utah.edu 的电子邮件经过验证
